Teacher Retirement System of Texas bought a new position in shares of USANA Health Sciences, Inc. (NYSE:USNA – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 32,908 shares of the company’s stock, valued at approximately $888,000. Teacher Retirement System of Texas owned approximately 0.17% of USANA Health Sciences as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Dimensional Fund Advisors LP boosted its holdings in USANA Health Sciences by 7.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock worth $27,751,000 after acquiring an additional 55,059 shares during the period. Geode Capital Management LLC boosted its stake in shares of USANA Health Sciences by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 301,949 shares of the company’s stock valued at $10,839,000 after buying an additional 4,829 shares during the last quarter. American Century Companies Inc. boosted its stake in shares of USANA Health Sciences by 12.3% during the 4th quarter. American Century Companies Inc. now owns 233,797 shares of the company’s stock valued at $8,391,000 after buying an additional 25,522 shares during the last quarter. Northern Trust Corp boosted its stake in shares of USANA Health Sciences by 16.5% during the 4th quarter. Northern Trust Corp now owns 135,937 shares of the company’s stock valued at $4,879,000 after buying an additional 19,266 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its stake in shares of USANA Health Sciences by 16.7% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 128,976 shares of the company’s stock valued at $4,629,000 after buying an additional 18,490 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Wall Street Zen upgraded USANA Health Sciences from a “hold” rating to a “buy” rating in a research note on Thursday, May 22nd.
USANA Health Sciences Price Performance
Shares of USNA opened at $32.51 on Tuesday. The business’s fifty day moving average price is $30.41 and its 200 day moving average price is $30.28. USANA Health Sciences, Inc. has a 12-month low of $23.10 and a 12-month high of $48.85. The stock has a market capitalization of $605.35 million, a PE ratio of 17.86, a price-to-earnings-growth ratio of 1.05 and a beta of 0.64.
USANA Health Sciences (NYSE:USNA – Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The company reported $0.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.70 by $0.03. USANA Health Sciences had a return on equity of 8.94% and a net margin of 3.98%. The firm had revenue of $249.54 million for the quarter, compared to analysts’ expectations of $243.08 million. During the same period last year, the business posted $0.86 earnings per share. As a group, research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.
Insider Buying and Selling at USANA Health Sciences
In other USANA Health Sciences news, CFO G Doug Iiekking sold 4,548 shares of the stock in a transaction on Friday, May 9th. The stock was sold at an average price of $29.61, for a total value of $134,666.28. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, COO Walter Noot sold 6,291 shares of the stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total value of $190,554.39. The disclosure for this sale can be found here. Insiders sold 12,013 shares of company stock worth $360,149 over the last ninety days. 0.63% of the stock is owned by corporate insiders.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Recommended Stories
- Five stocks we like better than USANA Health Sciences
- Investing in the High PE Growth Stocks
- These 3 Undervalued Stocks Could Surge as Value Rotation Nears
- Roth IRA Calculator: Calculate Your Potential Returns
- Tilray Shares Blazing: What’s Behind the 55% Rally This Month?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Retail Stocks to Watch as Back-to-School Spending Ramps Up
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA – Free Report).
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.